ERBB2 and breast cancer: It’s been reported that melittin induces TNBC and HER2-enriched breast cancer death by interfering with growth factor-dependent receptor tyrosine kinase (RTK) interactions critical for receptor phosphorylation and suppressing activation of PI3K/Akt signaling [36, 37].